Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors

Journal of Cellular Biochemistry

Volumn 72, Issue 1, 1999, Pages 67-80

  Faust, Judy ^a   Lacey, Dave L ^a   Hunt, Pamela ^a   Burgess, Teresa L ^a   Scully, Sheila ^a   Van, Gwyneth ^a   Eli, Alana ^a   Qian, Yi Xin ^a   Shalhoub, Victoria ^a  

^a AMGEN INC   (United States)

Author keywords

Bone resorption; Cathepsin K; Preosteoclast development; Tartrate resistant acid phosphatase; Vitronectin receptor

Indexed keywords

1 NAPHTHYL ACETATE ESTERASE; ACID PHOSPHATASE; CALCITONIN RECEPTOR; CATHEPSIN; FLUORIDE SODIUM; MESSENGER RNA; MONOCLONAL ANTIBODY; TARTARIC ACID; VITRONECTIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MONONUCLEAR CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; STEM CELL;

ACID PHOSPHATASE; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CARRIER PROTEINS; CATHEPSINS; CELL DIFFERENTIATION; CYTOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTEGRINS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NAPHTHOL AS D ESTERASE; OSTEOCLASTS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CALCITONIN; RECEPTORS, VITRONECTIN; STEM CELLS; TRANS-ACTIVATORS;

EID: 0032890449     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A     Document Type: Article

References (41)

1. Athanasou NA, Quinn J, Horton RIA, McGee JO'D. 1990. New sites of cellular vitronectin receptor immunoreactivity detected with osteoclast-reacting monoclonal antibodies 13C2 and 23C6. Bone Miner. 8:7-22.
2. Baron R, Neff L, Van FT, Nefussi J-R, Vignery A. 1986. Kinetic and cytochemcial identifiction of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Path 122:368-378.
3. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Manning CR, Jones C, Kurdyla JT, Mcnulty DE, Drake FH, Gowen M, Levy MA. 1996. Proteolytic activity of human osteoclast cathepsin K. J Biol Chem 271:1251712524.
4. Burgess TL, Ross SL, Qian Y-x, Brankow D, Hu S. 1995. Biosynthetic processing of neu differentiation factor. J Biol Chem 270:19188-19196.
5. Coccia PF, Krivit W, Cervenka J, Lawson C, Kersey JH, Kirn TH, Nesbit ME, Ramsay NKC, Warketin PI, Teitelbaum SL, Kahn AJ, Brown DM. 1980. Successful bone marrow transplantation for infantile malignant osteopetrosis. New Engl J Med 302:701-708.
6. Connor JR, Dodds RA, James IE, Gowen M. 1995. Human osteoclast and giant cell differentiation: The apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA. J Histochem Cytochem 43: 1193-1201.
7. Domon T, Wakita M. 1991a. Electron microscopic and histochemical studies of the mononuclear osteoclast of the mouse. Am J Anat 192:35-44.
8. Domon T, Wakita M. 1991b. The three-dimensional structure of the clear zone of a cultured osteoclast. J Electron Microsc 40:34-40.
9. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G, Gowen M. 1996. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511-12516.
10. Drexler HG, Gignac SM. 1994. Characterization and expression of tartrate-resistant acid phosphatase (TRAP) in hematopoietic cells. Leukemia 8:359-368.
11. Fujikawa Y, Quinn JMW, SabokbarA, McGee JO'D, Athanasou NA. 1996. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4058-4060.
12. Fuller K, Chambers TJ. 1987. Generation of osteoclasts in cultures of rabbit bone marrow and spleen cells. J Cell Physiol 132:441-452.
13. Grano M, Colucci S, de Bellis M, Zigrino P, Argentino L, Zambonin G, Serra M, Scotlandl K, Teti A, Zambonin Zallone A. 1994. New model for bone resorption study in vitro: Human osteoclast-like cells from giant cell tumors of bone. J Bone Miner Res 9:1013-1020.
14. Gregoretti MG, Bergui L, Aragno M, Cremona O, Marchisio PC, Caligaris-Capio F. 1995. Osteoclast precursors circulate in the peripheral blood of patients with aggressive multiple myeloma. Leukemia 9:1392-1397.
15. Hagenaars CE, van der Kraan AAM, Kawilarang-de Haas EWM, Visser JWM, Nijweide PJ. 1989. Osteoclast formation from cloned pluripotent hemopoietic stem cells. Bone Miner 6:179-189.
16. Hattersley G, Chambers TJ. 1989. Generation of osteoclasts from hemopoietic cells and a multipotential cell line in vitro. J Cell Physiol 140:478-482.
17. James IE, Dodds RA, Lee-Rykaczewski E, Eichman CF, Connor JR, Hart TK, Maleeff BE, Lackman RD, Gowen M. 1996. Purification and characterization of fully functional human osteoclast precursors. J Bone Miner Res 11:1608-1618.
18. Kahn AJ, Simmons DJ. 1975. Investigation of the cell lineage in bone using a chimera of chick and quail embryonic tissue. Nature 258:325-327.
19. Kassem M, Mosekilde L, Rungby J, Melsen F, Eriksen EF. 1991. Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures. APMIS 99:262-268.
20. Kaye M. 1984. When is it an osteoclast? J Clin Pathol 37:398-400.
21. Lacey DL, Erdmann JM, Teitelbaum SL, Tan H-L, Ohara J, Shioi A. 1995. Interleukin 4, Interferon- and Prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 136: 2367-2376.
22. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Caparelli C, Eli A, Qian Y-x, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
23. Marks SC, Popoff SN. 1988. Bone cell biology: The regulation of development, structure and function in the skeleton. Am JAnat 183:1-44.
24. Matayoshi A, Brown C, DiPersio JF, Haug J, Abu-Amer Y, Liapis H, Kuestner R, Pacifici R. 1996. Human bloodmobilized hematopoietic precursors differentiate into os-teoclasts in the absence of stromal cells. Proc Natl Acad Sei USA 93:10785-10790.
25. Orcel P, Bielakoff J, de Vernejoul M-C. 1990. Formation of multinucleated cells with osteoclast precursor features in human cord monocytes cultures. Anat Rec 226:1-9.
26. Owens JM, Gallagher AC, Chambers TJ. 1996. Bone cells required for osteoclastic resorption but not for osteoclastic differentiation. Biochem Biophys Res Commun 222: 225-229.
27. Purton LE, Lee MY, Torok-Storb B. 1996. Normal .human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood. Blood 87:1802-1808.
28. Roodman GD. 1995. Application of bone marrow cultures to the study of osteoclast formation and osteoclast precursors in man. Calcif Tissue Int 56(Suppl 1):S22-S23.
29. Roux C, Ravaud P, Cohen-Solal M, de-Vernejoul MC, Guillemant S, Cherruau B, Delmas P, Dougados M, Amor B. 1994. Biologic, histologie and densitometric effects of oral risedronate on bone in patients with multiple myeloma. Bone 15:41-49.
30. Roux S, Quinn J, Pichaud F, Orcel P, Chastre E, Jullienne A, de Vernejoul M-C. 1996. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone. J Cell Physiol 168:489-498.
31. SarmaU, FlanaganAM. 1996. Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood 88:2531-2540.
32. Sheven BAA, Visser JWM, Nijwiede PJ. 1986. In vitro osteoclast generation from different marrow fractions including a highly enriched haemopoietic stem cell population. Nature 321:79-81.
33. Soriano P, Montgomery C, Geske R, Bradley A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
34. Suda T, Takahashi N, Martin TJ. 1992. Modulation of osteoclast differentiation. Endocrine Reviews 13:66-80.
35. Sun T. 1985. Atlas of cytochemistry and immunochemistry of hematologie neoplasms. Chicago: American Society of Clinical Pathologists Press, pp. 34,111.
36. Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL. 1997. Osteopetrosis in mice lacking haematopoietic transcription factor PU.l. Letters to Nature 386:81-84.
37. Walker DG. 1973. Osteopetrosis cured by temporary parabiosis. Science 180:875.
38. Walker DG. 1975. Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through the use of bone marrow mononuclear phagocytes. J Exp Med 142:651-663.
39. Wilcox JN. 1993. Fundamental principles of in situ hybridization. J Histochem 41:1721-1723.
40. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
41. Zheng MH, Papadimitriou JM, Nicholson GC. 1991. A quantitative cytochemical investigation of osteoclasts and multinucleate giant cells. Histochem J 23:180-188.